Vernon K Sondak Selected Research

Vernon K Sondak Research Topics

Disease

160	Melanoma (Melanoma, Malignant) 04/2024 - 01/2002
86	Neoplasms (Cancer) 04/2024 - 01/2002
33	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2002
11	Merkel Cell Carcinoma 01/2022 - 05/2002
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2012
6	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2010
5	Skin Neoplasms (Skin Cancer) 01/2022 - 11/2008
5	Basal Cell Carcinoma (Rodent Ulcer) 01/2022 - 01/2011
5	Sarcoma (Soft Tissue Sarcoma) 02/2012 - 04/2004
4	Disease Progression 03/2023 - 05/2005
4	Infections 01/2021 - 01/2016
3	Diarrhea 01/2023 - 11/2008
3	Extranodal Extension 12/2022 - 06/2018
3	Carcinoma (Carcinomatosis) 01/2021 - 05/2003
3	Papillomavirus Infections 01/2016 - 11/2008
2	Exanthema (Rash) 09/2023 - 01/2021
2	Fatigue 01/2023 - 02/2015
2	Neoplasm Micrometastasis 12/2022 - 07/2005
2	COVID-19 01/2022 - 01/2021
2	Uveal melanoma 11/2020 - 01/2012
2	Nausea 02/2015 - 10/2010
2	Anemia 02/2015 - 01/2005
2	Leukemia 11/2014 - 04/2004
1	Acute Kidney Injury (Acute Renal Failure) 09/2023
1	Chronic Disease (Chronic Diseases) 01/2023

Drug/Important Bio-Agent (IBA)

18	IpilimumabIBA 10/2023 - 11/2008
14	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2023 - 04/2009
13	InterferonsIBA 01/2023 - 01/2002
13	Biomarkers (Surrogate Marker)IBA 06/2022 - 09/2006
11	VemurafenibIBA 09/2023 - 07/2011
11	VaccinesIBA 10/2014 - 01/2002
10	AntigensIBA 12/2022 - 01/2002
9	Interleukin-2 (IL2)IBA 01/2022 - 06/2003
9	Proteins (Proteins, Gene)FDA Link 04/2016 - 06/2003
9	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 02/2002
7	pembrolizumabIBA 10/2023 - 01/2017
6	Dacarbazine (DIC)FDA LinkGeneric 03/2015 - 04/2004
5	NivolumabIBA 10/2023 - 01/2017
5	Interferon alpha-2 (Roferon-A)FDA Link 01/2023 - 03/2002
5	Immune Checkpoint InhibitorsIBA 12/2022 - 10/2019
4	Interferon-alpha (Interferon Alfa)IBA 01/2022 - 01/2003
4	AntibodiesIBA 01/2021 - 06/2013
4	LigandsIBA 03/2015 - 12/2008
4	Phosphotransferases (Kinase)IBA 12/2014 - 04/2004
4	Histocompatibility Antigens Class IIBA 10/2014 - 04/2002
4	MelacineIBA 10/2014 - 04/2002
4	Cancer VaccinesIBA 06/2003 - 01/2002
4	Peptides (Polypeptides)IBA 06/2003 - 01/2002
3	RNA (Ribonucleic Acid)IBA 09/2023 - 01/2021
3	InterleukinsIBA 01/2022 - 12/2008
3	Messenger RNA (mRNA)IBA 10/2019 - 08/2013
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2017 - 09/2004
3	Cisplatin (Platino)FDA LinkGeneric 11/2014 - 04/2004
3	ORALIT (ORS)IBA 05/2014 - 08/2012
3	Mitogen-Activated Protein KinasesIBA 01/2014 - 01/2012
3	Hematoxylin (Haematoxylon)IBA 10/2010 - 05/2002
3	Eosine Yellowish-(YS) (Eosin)IBA 10/2010 - 05/2002
3	Imatinib Mesylate (Gleevec)FDA Link 10/2010 - 01/2008
3	HLA Antigens (Human Leukocyte Antigens)IBA 09/2010 - 10/2002
2	cobimetinibIBA 09/2023 - 11/2020
2	Small Cytoplasmic RNAIBA 01/2022 - 01/2021
2	Viral DNAIBA 01/2021 - 01/2021
2	dabrafenibIBA 11/2020 - 12/2016
2	trametinibIBA 11/2020 - 01/2018
2	Keratins (Keratin)IBA 01/2020 - 05/2003
2	Vinblastine (Vinblastine Sulfate)FDA Link 11/2014 - 12/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2014 - 01/2005
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2014 - 04/2002
2	tyrosine receptor (receptor, tyrosine)IBA 07/2014 - 02/2005
2	Carboplatin (JM8)FDA LinkGeneric 05/2014 - 01/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 01/2012
2	Type 1 Melanocortin ReceptorIBA 08/2013 - 12/2012
2	Small Interfering RNA (siRNA)IBA 06/2013 - 04/2011
2	ErbB Receptors (EGF Receptor)IBA 05/2013 - 02/2005
2	Coloring Agents (Dyes)IBA 02/2013 - 01/2013
2	Sorafenib (BAY 43-9006)FDA Link 02/2012 - 01/2012
2	Thalidomide (Thalomid)FDA Link 01/2010 - 11/2007
2	Indicators and Reagents (Reagents)IBA 07/2009 - 02/2008
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2008 - 01/2003
2	Protein Subunit VaccinesIBA 01/2003 - 01/2002
1	Histones (Histone)IBA 02/2024
1	ChromatinIBA 02/2024
1	relatlimabIBA 10/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2023
1	CTLA-4 AntigenIBA 04/2023

Therapy/Procedure

91	Therapeutics 12/2023 - 01/2002
29	Immunotherapy 12/2022 - 01/2002
20	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 01/2003
16	Drug Therapy (Chemotherapy) 01/2018 - 02/2002
12	Radiotherapy 01/2022 - 09/2007
7	Neoadjuvant Therapy 03/2023 - 01/2017
5	Chemoprevention 01/2019 - 03/2005
2	Metastasectomy 01/2024 - 08/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2022 - 01/2018
2	Adjuvant Radiotherapy 06/2020 - 05/2014
2	Biological Therapy 11/2014 - 05/2011
2	Palliative Care (Palliative Therapy) 01/2010 - 07/2007
1	Intralesional Injections 04/2024
1	Drug Tapering 09/2023
1	Molecular Targeted Therapy 08/2023